0001209191-23-049792.txt : 20230918 0001209191-23-049792.hdr.sgml : 20230918 20230918173457 ACCESSION NUMBER: 0001209191-23-049792 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230914 FILED AS OF DATE: 20230918 DATE AS OF CHANGE: 20230918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Loewen Andrea CENTRAL INDEX KEY: 0001591100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 231261977 MAIL ADDRESS: STREET 1: C/O VITAL THERAPIES, INC. STREET 2: 15010 AVENUE OF SCIENCE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-14 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001591100 Loewen Andrea 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 SVP, Global Regulatory Affairs 0 Class A common stock 2023-09-14 4 S 0 3175 172.0254 D 28416 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $172.02 to $172.035. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Tracy Herson, attorney-in-fact 2023-09-18